TrialRetrovirology2016

First Phase I human clinical trial of a killed whole-HIV-1 vaccine: demonstration of its safety and enhancement of anti-HIV antibody responses.

Eunsil Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.